https://www.selleckchem.com/pr....oducts/R788(Fostamat
6%) (p = 0.042). Accordingly, mortality was 14.7% vs. 0.5% (p less then 0.0001). Persistent shedding was significantly associated with persistent dyspnea and anosmia/ageusia (p less then 0.05). In the context of COVID-19 treatment, including treatment with azithromycin plus hydroxychloroquine, the persistence of SARS-CoV-2 nasopharyngeal shedding was a rare event, most frequently encountered in elderly patients with comorbidities and lacking azithromycin plus hydroxychloroquine treatment.Although the structure of ver
Like
Comment
Share
